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Abstract 
In this study; a total of 150 hyperprolactinemic women their ages (20-50) years are collected from Kmal Al-
Samaraee hospital and 50 for normal healthy women used as control. The patients were divided into two groups, 
those who suffer from primary infertility  and those who suffered from secondary infertility, then the 150 patient 
groups were divided into three age groups (20-30), (31-40) and (41-50) years. Test of fertility hormones, which 
is (LH and FSH)was done for all patient groups to check the effect of high prolactin levels on the level of other 
hormones. It was found that there is a significant difference in all hormones concentrations (LH,FSH,PRL) for 
patients when compared with normal healthy groups hormones, according to type of fertility,  both in primary  
and secondary infertile   women. The results show that the prolactin levels in both infertile groups were higher 
than in normal, healthy, fertile women which lead to decrease the concentration of fertility hormones.   Also, it 
is obvious that the prolactin level in secondary infertile women higher than its level in the primary infertile 
patients. The results indicate that the higher prolactin levels were in the age group (31-40) years, than of the 
other two groups. 
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1. Introduction 
There is a wide range of studies considering the infertility problem and causes among women’s. Prolactin(PRL) 
hormone is a peptide hormone which synthesized by lactotropes thatproduced by the pituitary gland, which  
located in the base ofthe brain  and that can highly effected on women’s reproduction due to its  effect on 
fertility hormones[1]. It starts its activity via binding to a specific receptor which a single membrane bound 
protein [2]. The other extra-pituitary sources are breast tissue, brain and immune cells [3,4,5].  
Hyperprolactinemia is a condition in which presence of abnormally high level of prolactin hormone in the blood 
of non-lactating and nonpregnant women in which the normal levels are typically 10–35 ng/ml and 1ng is 
equivalent to 21.2 mU/ml [6]. Hyperprolactinemia is the major cause of female infertility, the elevated prolactin 
level affects a women’s ovulation and menstrual cycles this by inhibiting the fertility hormone which is follicle 
stimulating hormone and leutilizing hormone  
 An excessive PRL secretion decreases the pulsatile release of GnRH impairing the pituitary production of FSH 
and LH. Furthermore, it may directly impair the endocrine activity of ovarian follicles. As a consequence 
defective luteal phase, inconstant ovulation and chronic an ovulation are conditions frequently observed in 
young hyperprolactinemic patients [7].` Primary infertility was defined as those cases in whom conception had 
never occurred and secondary infertility was defined as those cases in whom there was an inability to conceive 
after a previous successful conception. 
2. Aim of the work 
Identification of the effect of high prolactin hormone level (hyperprolactinemia) on two other fertility hormones, 
leutilizing hormone (LH) and follicle stimulating hormone (FSH) in Iraqi women patients and to check the 
effect of this effect on three ages group in two type of fertility (first and second infertile women). 
3. Materials and methods 
Blood samples were collected from 150 randomly selected hyperprolactinemic infertile women, blood 
specimens also collected from fertile non-pregnant and non-lactating 50 healthy women with no past history of 
hyperprolactinemia. All these samples were obtained from infertility hospital of Kamal AL-Samraee starting 
from March 2014 to Septembers 2014.Hormonal assay of   fertility hormone  levels was measured using Bio-
merieux (France)and data was recorded which is age, detailed medical history, duration of the infertility 
problem and type of infertility suffered by the patients. 
Then the 150 patients were arranged depending on ages into three groups which is (20-30), (30-40) and (41-50) 
years old, to check in which age group the effect is. Statistical analysis  for all values were expressed as Mean± 
Standard Deviation of the  (M±SD). P value are 0.05 was regarded as statistically significant. 
Statistical analysis forboth groups was carried out on the data obtained using Minitab  15 software. ANOVA test 
was used first to compare two infertile groups to check the effect of hyperprolactinemia in these two groups then 
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also used to compare different age groups among each other and with control 
4. Result 
A total of two hundred  samples was taken, of whom one hundred fifty sample ofhyperprolactinemic infertile 
women  this group  screened  as case group and fifty were fertile healthy group as a control. There were 75% 
infertile hyperprolactinemic women in case group whichinclude Group 1comprised 64.6% primary infertile 
women and Group 2include 35.09% secondary infertile hyperprolactinemicpatients.These groups  distributed as 
shown in table1 and  figure1, as 200 represent whole group study, 97(64.6%) were primarily infertile women, 
53(35.4%) as secondary infertile women and 50 as healthy control.  
Table 1: Frequency and percent of the whole group, control group, first infertility  and second  infertility case 
group. 
Percent Frequency Sample 
100% 
 
200 Study group 
 
25% 50 Control 
 
75% 150 Hyperprolactinemia 
 
64.6% 
 
35.4% 
 
97 
 
53 
 
 
First infertility 
 
 
Second infertility 
9.673 ** 
0.0139 
--- 
--- 
Chi-square (χ2) 
P-value 
**  (P<0.01). 
 
Figure 1: Distribution study of groups 
Total
patients
Infertile 1 Infertile2 Control
150 
97 53 50 
Number of Samples 
338 
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The patients were divided into two groups, those who suffer from primary infertility  and those who suffered 
from secondary infertility, then the 150 patient groups were divided into three groups according to age,  which is 
(20-30), (31-40) and (41-50) years. Test of fertility hormones, which is (LH and FSH) was done for all patient 
groups to check the effect of high prolactin levels on the level of them. 
Effect of hyperprolactinemia on fertility hormones. 
 Screening of hyperprolactinemia according to  fertility hormones which is (LH, FSH) that affected by increased 
prolactin level, give the results as shown in table (2).  
Table 2: Measurement of prolactin, LH and FSH in females with hyperprolactinemia. 
Ages No. of total 
cases. 
Measured 
concentration 
Normal 
concentration 
Hormone 
type 
 
 
20-50 
 
 
150 
30-114 ng/ml 1.3-25 ng/ml Prolactin 
1-4.5mlU/ml 1.5-8 mlU/ml LH 
0.8-3.59 
mlU/ml 
3.9-12 mlU/ml FSH 
The  prolactin hormone level was increased in hyperprolactemic patients and have effect on decreasing the two 
fertility hormones (LH and FSH), is clear in table (3), and it’s shown that the mean of prolactin hormone level in 
hyperprolactemic patients is 42.18 ± 12.64, while for control healthy is 10.84±4.67, this higher difference is 
statically significance as the difference between mean value of two group (control and patients) is higher than 
the LSD value which is 8.306. For LH hormone the decrease of level of this hormone in hyperprolactemic 
patient is highly significance as the difference of mean value for both group (Patient and control) is higher than 
LSD for this hormone which is 1.941, also same was for the other fertility hormone (FSH), in which it decreased 
in hyperprolactemic patients than in healthy control groups when the difference of mean value is higher than 
LSD which is 2.853. 
Table 3: Effect of hyperprolactinemia on the fertility hormones level in comparison with control group 
Hormone Mean ± SD LSD value 
Control Patients 
Prolactin 10.84±4.67 42.18 ± 12.64 8.306 ** 
LH 5.700±1.809 2.60 ± 0.937 1.941 ** 
FSH 8.251±2.477 3.71 ± 1.077 2.853 ** 
** (P<0.01). 
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Hyperprolactinemic patients, according to type of infertility 
 Screening of 150 hyperprolactinemic female, according to their type of infertility with their fertility hormones 
gave the results shown in table (4). 
As shown in table (4), the measurements of fertility hormones   for both first  and second infertile women and 
on comparison of the prolactin levels and fertility hormones in primary  and in secondary infertile women ,  and 
the p value was obtained. It was found increase in prolactin level in  secondary infertile women  than in  first  
infertile women when  the mean is 41.1±11.8 in first  infertile group and 44.0±16.1  in second  infertile group, 
but the difference of PRL hormone level between two groups (first and second infertile), is 3.1 and this value is 
statically non-significant as  its less than T-value which is 8.029.   For FSH hormone its clear that the level of it 
is decrease in second infertile group in which its mean is 3.55±1.43, but its higher in first infertile group when 
its mean is 3.80± 1.13. This increase is not significant  as the difference between the level of this two hormone 
is 0.25 which is less than T-value (0.972). Also for the other fertility hormone (LH), it’s clear from the table 
above that its level is higher in first infertile group in which the mean is 2.61± 1.05 but in second group is 
2.59±1.18, and the difference between this two groups is 0.02 and its less than T-value 0.619 so the decreases in 
hormone level in second infertile women is not significant. 
Table 4: Group Statistics of first and second infertile women by mean, Std. Deviations and T-Value >0.05, N= 
number). 
Fertility type N Mean St.Dv T- value 
Prolactin 
 
 
Primary 97 41.1 11.8  
8.029 NS Secondary 53 44.0 16.1 
FSH 
 
 
Primary 97 3.80 1.13  
0.972 NS Secondary 53 3.55 1.43 
LH Primary 97 2.61 1.05  
0.619 NS Secondary 53 2.59 1.18 
NS: Non-significant 
A graphical representation of  fertility hormones according to type of infertility is shown in figures (2),(3) and 
(4) regarding to PRL, FSH and LH respectively. 
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Figure 2: Prolactin levels in hyperprolactinemic infertile women categorized according to infertility type, (35, 
40, 45 ) refers to hormone range 
 
Figure 3: FSH levels in hyperprolactinemic infertile women categorized according to infertility type. (3, 3.5 and 
4) refer to hormone range. 
Hyperprolactinemic patients according to three age groups and  types of fertility hormones. 
The results in table 5, show the measurements of prolactin hormone were increased with each infertile group 
while the fertility hormones (LH and FSH) were decreased compared with the control group. 
 
Figure 4: FSH  levels in hyperprolactinemic infertile women categorized according to infertility type.(2.55, 2.6 
and 2.65 refers to hormone range). 
The serum prolactin means and SD is 38.56±12.59, 44.10±14.98 and 43.87±12.12.49 in the three ages infertile 
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groups while its 10.84±4.67 in the control group.    It was shown from the table (3- 5),  that the elevation in 
prolactin hormone is more in  age group (31-40) years old among those other two groups (20-30), (41-50),  with 
mean ±standard deviation of 44.10±14.98, but   the elevation is less in group 20-30 in which the mean is 38.56 
±12.59 and noticing age group 41-50 years old the prolactin level is with mean of 43.87±12.49 only in 
comparison with age group 31-40 years old. This differences in PRL hormone level with three ages group is not 
significant as the difference between hormone level in above ages group is less than the LSD value which is 
9.337. For the LH hormone, the decrease in level of it is more in age group  41-50 years old, with mean 
2.451±1.078, and also decreased in the other two ages group (20-30), (31-40) years old, but the decrease in 
hormone level between three ages group is non significant as the difference between levels of hormone for this 
three groups is less than LSD value which is 0.502. In contrast for the third hormone FSH its noticed that this 
hormone is decreased significantly  in all ages group as the difference of level of this hormone is more than the 
LSD value which is 0.638. 
Table 5: Statistical  analysis of fertility measurement of hyperprolactemic  females categorized  according to 
age. 
 
Control 
 
(Mean±SD) 
 
LSD value Age group  
Hormone 
 
41-50 
(Mean±SD) 
 
 
31-40 
(Mean±SD) 
 
 
20-30 
(Mean±SD) 
 
10.84±4.67 9.337 NS 43.87±12.49 A 44.10±14.98 A 38.56±12.59 A Prolactin 
5.700±1.809 0.502 NS 2.451±1.078 A 2.594±1.256 A 2.756±0.925 A LH 
8.251±2.477 0.638 * 3.199±1.168 B 4.007±1.436 A 3.915±0.956 A FSH 
 
5. Discussions 
The result of this study revealed elevated prolactin concentrations in infertile subjects.  By comparison between 
two infertile groups it was found that prolactin value of (44.0±16.1) in secondary infertile women was higher 
than the prolactin value in primary infertile women which is (41.0±11.8). The result is coinciding with the study 
of Solomon et al (2013) stated that   the concentration of prolactin has been always higher in secondary infertile 
women than the primary infertile women. (7).  Also, according to Al- Muhammadi et al (2012) this is probably 
due to that the patients with secondary infertility consult a specialist less frequently than others because they are 
in less urge for seeking medical help since they already got children.(8). This delay in the treatment could be 
due to the fact that these cases had a  marginal elevation of the prolactin and were not having any additional 
symptoms except infertility, so they waited for a longer period. 
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Figure 5: PRL level in three patient groups according to age and control group.(0, 20, 40 and 60 ng/ml) reffered 
to hormone range. 
 
Figure 6: FSH level in three patient groups according to age and control group.(0, 2, 4, 6, 8 and 10 mlU/ml), 
referred to hormone range. 
 
 
Figure 7: LH level in three patient groups according to age and control group.(0, 1, 2, 3, 4, 5 and 6 mlU/ml), 
refered to hormone range. 
Also the obvious results showed that  the highly significant increase in serum prolactin level in both infertile 
groups will lead to a significant decrease in serum LH and FSH as the mean of  FSH is (3.80), (3.55) (mIU/ml) 
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for both infertile groups, respectively, and of LH (2.61)(2.59) (mIU/ml) for primary and secondary infertility 
group respectively, so in different groups of hyperprolactinemic women an increase in serum prolactin level and 
a decrease in other fertility hormones and this happened more in  women with  secondary infertility   than 
women with primary infertility. Also in different age groups of hyperprolactinemic women, an increase in serum 
prolactin level and variation in other hormonal levels was observed, and its clear that this happened more in 
women with group age 30-40 years, as it shown in the figures (3-3) and (3-4). 
This result coincides with the study of Lee et al., (2012) that showed hyperprolactinemia decreases the pulsatile 
secretion of gonadotrophin-releasing hormone impairing the release of LH and FSH (9),  It’s clear the more 
increase in prolactin level among different age group was happening in age thirties, and its well-known that age 
plays an important role in female infertility, however, in this study the correlation between them is clear as the 
mean value of increasing prolactin level was in one age group than in another one (10). 
    This support that, when abnormal elevation started it will continue and may remain in women(10). 
6. Conclusion 
In conclusion, it can conclude from this study that in different groups of hyperprolactinemic women an increase 
in serum prolactin level and a decrease in other fertility hormones and this happened more in  women with  
secondary infertility  than women with primary infertility. Also the present study revealed that in different age 
groups of hyperprolactinemic women, an increase in serum Prolactin level and variation in other hormonal 
levels was observed, and it's clear that this happened more in women with group age 30-40. 
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